收藏切换
Observation on the safety of dabigatran in elderly atrial fibrillation patients with mild to moderate renal dysfunction after radiofrequency ablation
收藏切换
Hong-mei ZHOU, Jin XU*, Qing ZHANG, Qi ZHANG, Meng JIANG, Jun BU
World Clinical Drug | 2018, 39(12) : 826 - 831
Less
收藏切换
World Clinical Drug | 2018, 39(12): 826-831
• Article •
Observation on the safety of dabigatran in elderly atrial fibrillation patients with mild to moderate renal dysfunction after radiofrequency ablation
Full
Hong-mei ZHOU, Jin XU*, Qing ZHANG, Qi ZHANG, Meng JIANG, Jun BU
Affiliations
  • Department of Cardiovascular, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200001, China
Published: 2018-12-10 doi: 10.13683/j.wph.2018.12.007
Outline
收藏切换
Objective

To observe the safety of dabigatran applied in elderly patients with atrial fibrillation and mild/moderate renal dysfunction after radiofrequency ablation.

Methods

A total of 94 elderly atrial fibrillation patients in hospital were selected, and divided into normal renal function group(n=27)and mild renal dysfunction group(n=51)and moderate renal dysfunction group(n=16)based on patients’ estimated glomerular filtration rate (eGFR). All three groups received radiofrequency ablation treatment, and the anticoagulant therapy started with dabigatran (110 mg twice a day) at 6 hours after operation. The renal and liver function and the blood cell data of these patients were measured at the before operation, 48 hours after operation and 1 month after operation. And three months continuous observation for the occurrence of embolization and hemorrhage was made.

Results

There were no major bleeding events in the three groups of patients, who received dabigatran as anticoagulant therapy. There was no significant difference in thromboembolic events among the three groups, and neither the reduction in liver and kidney function. In the three group patients treated with dabigatran, no peripheral blood cell reduction was observed.

Conclusion

As an anticoagulant, dabigatran can safely use for the elderly atrial fibrillation patients with mild/moderate renal dysfunction after radiofrequency ablation.

atrial fibrillation  /  renal dysfunction  /  dabigatran  /  radiofrequency ablation
周红梅, 徐瑾, 张清, 张琪, 姜萌, 卜军. 达比加群酯应用于轻中度肾功能不全的老年心房颤动患者射频消融术后的安全性观察. 世界临床药物, 2018 , 39 (12) : 826 -831 . DOI: 10.13683/j.wph.2018.12.007
Hong-mei ZHOU, Jin XU, Qing ZHANG, Qi ZHANG, Meng JIANG, Jun BU. Observation on the safety of dabigatran in elderly atrial fibrillation patients with mild to moderate renal dysfunction after radiofrequency ablation[J]. World Clinical Drug, 2018 , 39 (12) : 826 -831 . DOI: 10.13683/j.wph.2018.12.007
Year 2018 volume 39 Issue 12
15
4
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2018.12.007
  • Receive Date:2018-09-27
  • Online Date:2026-11-18
  • Published:2018-12-10
Article Data
Affiliations
History
  • Received:2018-09-27
  • Revised:2018-10-09
Funding
Affiliations
    Department of Cardiovascular, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200001, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2018.12.007
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT